Senior Research Investigator
Current- Investigation on small molecules acting as positive allosteric modulators (PAMs) of Glucagon-like Peptide 1 Receptor (GLP1R) used in diabetes type-2 treatment
- Developing PAMs of Formyl Peptide Receptor 2 (FPR2) for the treatment of heart disease
- Using CRISPR technology to knock-in genes and generation of stable cell lines expressing GLP-1R, CRE promoter driven luciferase reporter gene, insulin with Luciferase-fused C-peptide.